Bladder Cancer,Genitourinary Cancer TAR-200 + CET vs CET Alone in Patients With MIBC: SR-4 Interim Sep 19, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Efficacy of Low vs Standard Pembrolizumab in NSCLC Sep 19, 2024
Breast Cancer,TNBC (Triple Negative Breast Cancer) Improved OS with Neoadjuvant Pembrolizumab in Early TNBC Sep 19, 2024
Genitourinary Cancer,Prostate Cancer DARO Enhances Survival and Efficacy in Metastatic Prostate Cancer Sep 19, 2024
AML (Acute Myeloid Leukemia),Leukemia Impact of TBI on Secondary Malignancies in AML Survivors Sep 18, 2024
Lung Cancer,SCLC (Small Cell Lung Cancer) Consolidation Durvalumab Enhances Survival in LS-SCLC vs Placebo Sep 18, 2024
Gastric Cancer,Gastrointestinal Cancer Periop Chemo Alone vs Preop CRT in Resectable Gastric Cancer Sep 18, 2024
Colorectal Cancer,Gastrointestinal Cancer Efficacy of Ramucirumab Plus TAS102 in Heavily Treated mCRC Sep 18, 2024
